W. Rod Hardy - Concepedia

Author

W. Rod Hardy

Lunenfeld-Tanenbaum Research Institute ORCID

Also Known As

W R Hardy, W Rod Hardy, W. R. Hardy, W. Rod Hardy, W.R. Hardy, WILLIAM R. HARDY, William Hardy, William R. Hardy, William Rod Hardy

Publications

2.8K

Citations

H-Index

128

Concepts

All Affiliations

Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital University of Toronto McMaster University University Health Network

About

W. Rod Hardy is an author at Lunenfeld-Tanenbaum Research Institute specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	1.9K
2	Natural Sciences	8	8	339
3	Engineering	5	5	79
4	Health Sciences	1	1	495
5	Allergy	1	1	495

W. Rod Hardy

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
The Hypereosinophilic Syndromes W. Rod Hardy Annals of Internal Medicine PathologyEosinophilic DisorderHypereosinophilic SyndromesSurgical PathologyHematology	1968	495
Temporal regulation of EGF signalling networks by the scaffold protein Shc1 Yong Zheng, Cunjie Zhang, David R. Croucher, Nature Signal TransductionSignaling PathwayCell RegulationScaffold Protein Shc1Receptor Tyrosine Kinase	2013	290
Amplification of the <i>neu/erbB-2</i> oncogene in a mouse model of mammary tumorigenesis Eran R. Andrechek, W. Rod Hardy, Peter M. Siegel, Proceedings of the National Academy of Sciences	2000	229
Novel Activating Mutations in the <i>neu</i> Proto-oncogene Involved in Induction of Mammary Tumors Peter M. Siegel, David Dankort, W. Rod Hardy, Molecular and Cellular Biology Breast OncologyMammary TumorsCancer BiologyWild-type Neu ReceptorMammary Gland Development	1994	188
ShcA signalling is essential for tumour progression in mouse models of human breast cancer Josie Ursini‐Siegel, W. Rod Hardy, Dongmei Zuo, The EMBO Journal Tumor BiologyBreast OncologyMedicineTumour ProgressionCancer Growth	2008	159
Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Peter M. Siegel, David Dankort, W. Rod Hardy, Molecular and Cellular Biology Breast OncologyMammary TumorsCancer BiologyWild-type Neu ReceptorNeu Proto-oncogene	1994	150
ErbB2 Is Required for Muscle Spindle and Myoblast Cell Survival Eran R. Andrechek, W. Rod Hardy, Adele Girgis-Gabardo, Molecular and Cellular Biology	2002	124
Screening for PTB Domain Binding Partners and Ligand Specificity Using Proteome-Derived NPXY Peptide Arrays Matthew J. Smith, W. Rod Hardy, James M. Murphy, Molecular and Cellular Biology Peptide EngineeringMolecular BiologyPeptide MotifsProteomic TechnologySignaling Pathway	2006	108
The Catalytic Activity of the ErbB-2 Receptor Tyrosine Kinase Is Essential for Embryonic Development Richard Chan, W. Rod Hardy, Michael A. Laing, Molecular and Cellular Biology Egfr FamilySignal TransductionDevelopmental BiologyErbb-2 Knockout MutantsSignaling Pathway	2002	72
Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine Deepali Kumar, Queenie Hu, Reuben Samson, American Journal of Transplantation	2022	71

Page 1